EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Factors Associated With Dupilumab Efficacy in Patients With Chronic Rhinosinusitis With Nasal Polyps

Shinya Takaishi iD, Nobuyoshi Otori

OTO Open · 2026-04 · 10 (2)

DOI: 10.1002/oto2.70241 ↗

Kurz gefasst

Fachartikel in der Zeitschrift OTO Open, online erschienen am 25.05.2026. Verfasst von Shinya Takaishi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology Jikei University School of Medicine Tokyo Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Dupilumab is effective in treating patients with intractable chronic rhinosinusitis with nasal polyps (CRSwNP); however, the factors influencing its efficacy remain unclear. Systemic corticosteroids (SCS) are occasionally administered to patients receiving dupilumab; however, concomitant use can obscure the efficacy of dupilumab. The present study aimed to investigate the factors associated with the efficacy of dupilumab, while minimizing the influence of SCS. Study Design Retrospective longitudinal study.

Setting

A single academic hospital.

Methods

We retrospectively evaluated medical records of 193 patients who started dupilumab for CRSwNP at our institution between March 2020 and July 2023. Patients who were prescribed SCS even once during a specific period were excluded. Finally, 50 patients were enrolled. We assessed correlations between pre‐treatment parameters (age, time since last sinus surgery, blood eosinophil count, blood eosinophil proportion, and serum total immunoglobulin E) and endpoints (changes in nasal polyp score, nasal congestion score, and Lund‐Mackay computed tomography score [LMK‐CTS] from baseline). Additionally, the endpoints were compared between subgroups (male vs female, presence vs absence of asthma, presence vs absence of nonsteroidal anti‐inflammatory drug‐exacerbated respiratory disease, and three groups classified according to the blood eosinophil proportion).

Results

Statistically, neither significant differences between the subgroups nor significant correlations between the parameters and the endpoints were observed, except for a correlation between the blood eosinophil proportion and the changes in LMK‐CTS ( r = 0.47, P = .037 [n = 21]).

Conclusion

Although a higher baseline peripheral blood eosinophil percentage may be associated with smaller changes in LMK‐CTS, our findings need further investigation.

Schlagwörter

Stichwörter der Autor:innen

Lund‐Mackay computed tomography scorechronic rhinosinusitis with nasal polypsdupilumabnasal congestion scorenasal polyp scoreproportion of blood eosinophilssystemic corticosteroidstype 2 inflammation

Autor:innen und Institutionen

  • Department of Otorhinolaryngology Jikei University School of Medicine Tokyo Japan.

ORCID-Profile: Shinya Takaishi

Zitieren

APA

Takaishi, S., & Otori, N. (2026). Factors Associated With Dupilumab Efficacy in Patients With Chronic Rhinosinusitis With Nasal Polyps. OTO Open, 10(2). https://doi.org/10.1002/oto2.70241

Vancouver

Takaishi S, Otori N. Factors Associated With Dupilumab Efficacy in Patients With Chronic Rhinosinusitis With Nasal Polyps. OTO Open. 2026;10(2). doi:10.1002/oto2.70241

BibTeX
@article{Takaishi2026,
  author = {Takaishi, Shinya and Otori, Nobuyoshi},
  title = {Factors Associated With Dupilumab Efficacy in Patients With Chronic Rhinosinusitis With Nasal Polyps},
  journal = {OTO Open},
  year = {2026},
  volume = {10},
  number = {2},
  doi = {10.1002/oto2.70241}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche